BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29984665)

  • 21. Analysis of circulating microRNAs in patients with repaired Tetralogy of Fallot with and without heart failure.
    Abu-Halima M; Meese E; Keller A; Abdul-Khaliq H; Rädle-Hurst T
    J Transl Med; 2017 Jul; 15(1):156. PubMed ID: 28693530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating miR-200-family micro-RNAs have altered plasma levels in patients with endometriosis and vary with blood collection time.
    Rekker K; Saare M; Roost AM; Kaart T; Sõritsa D; Karro H; Sõritsa A; Simón C; Salumets A; Peters M
    Fertil Steril; 2015 Oct; 104(4):938-946.e2. PubMed ID: 26206343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulated Expression of Circulating MicroRNAs in Kidney Transplant Recipients With Interstitial Fibrosis and Tubular Atrophy.
    Zununi Vahed S; Poursadegh Zonouzi A; Ghanbarian H; Ghojazadeh M; Samadi N; Ardalan M
    Iran J Kidney Dis; 2017 Jul; 11(4):309-318. PubMed ID: 28794294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Circulating Serum MicroRNA as Diagnostic Biomarkers for Multiple Myeloma].
    Xu YN; Xiao CR; Huang YD; Lu QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):471-475. PubMed ID: 28446295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absolute Measurement of Cardiac Injury-Induced microRNAs in Biofluids across Multiple Test Sites.
    Thompson KL; Boitier E; Chen T; Couttet P; Ellinger-Ziegelbauer H; Goetschy M; Guillemain G; Kanki M; Kelsall J; Mariet C; de La Moureyre-Spire C; Mouritzen P; Nassirpour R; O'Lone R; Pine PS; Rosenzweig BA; Sharapova T; Smith A; Uchiyama H; Yan J; Yuen PS; Wolfinger R
    Toxicol Sci; 2016 Nov; 154(1):115-125. PubMed ID: 27605421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing sample and miRNA profile quality in serum and plasma or other biofluids.
    Blondal T; Jensby Nielsen S; Baker A; Andreasen D; Mouritzen P; Wrang Teilum M; Dahlsveen IK
    Methods; 2013 Jan; 59(1):S1-6. PubMed ID: 23036329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma.
    Zhou G; Lu M; Chen J; Li C; Zhang J; Chen J; Shi X; Wu S
    Tumour Biol; 2015 Nov; 36(11):8845-52. PubMed ID: 26069101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients.
    Huo D; Clayton WM; Yoshimatsu TF; Chen J; Olopade OI
    Oncotarget; 2016 Aug; 7(34):55231-55248. PubMed ID: 27409424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
    Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
    Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on the Sample Preservation Temperature and Period in Circulating MicroRNA Quantification Using Spike-In Control].
    Aiso T; Sekine N; Takagi Y; Ohnishi H
    Rinsho Byori; 2015 Jun; 63(6):688-93. PubMed ID: 26548232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of RNA isolation methods for microRNA quantification in a range of clinical biofluids.
    Roest HP; IJzermans JNM; van der Laan LJW
    BMC Biotechnol; 2021 Aug; 21(1):48. PubMed ID: 34362351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of micro-RNA Profile in the Blood of Patients with Marfan's Syndrome.
    Abu-Halima M; Ludwig N; Rädle-Hurst T; Keller A; Motsch L; Marsollek I; El Rahman MA; Abdul-Khaliq H; Meese E
    Thorac Cardiovasc Surg; 2018 Jan; 66(1):116-124. PubMed ID: 28679133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of the preanalytical variables affecting the measurement of clinically relevant free-circulating microRNAs: focus on sample matrix, platelet depletion, and storage conditions.
    Faraldi M; Sansoni V; Perego S; Gomarasca M; Kortas J; Ziemann E; Banfi G; Lombardi G
    Biochem Med (Zagreb); 2020 Feb; 30(1):010703. PubMed ID: 31839723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevance of pre-analytical blood management on the emerging cardiovascular protein biomarkers TWEAK and HMGB1 and on miRNA serum and plasma profiling.
    Basso D; Padoan A; Laufer T; Aneloni V; Moz S; Schroers H; Pelloso M; Saiz A; Krapp M; Fogar P; Cornoldi P; Zambon CF; Rossi E; La Malfa M; Marotti A; Brefort T; Weis TM; Katus HA; Plebani M
    Clin Biochem; 2017 Mar; 50(4-5):186-193. PubMed ID: 27847340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
    Xiang M; Zeng Y; Yang R; Xu H; Chen Z; Zhong J; Xie H; Xu Y; Zeng X
    Biochem Biophys Res Commun; 2014 Nov; 454(1):210-4. PubMed ID: 25450382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards Clinical Applications of Blood-Borne miRNA Signatures: The Influence of the Anticoagulant EDTA on miRNA Abundance.
    Leidinger P; Backes C; Rheinheimer S; Keller A; Meese E
    PLoS One; 2015; 10(11):e0143321. PubMed ID: 26599228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer.
    Motawi TM; Sadik NA; Shaker OG; Ghaleb MH
    Tumour Biol; 2016 Jul; 37(7):9865-74. PubMed ID: 26812693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
    Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
    BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
    Lian F; Cui Y; Zhou C; Gao K; Wu L
    PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer.
    Oze I; Shimada S; Nagasaki H; Akiyama Y; Watanabe M; Yatabe Y; Matsuo K; Yuasa Y
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):551-554. PubMed ID: 27909811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.